China Universal Asset Management Co., Ltd. Omega Therapeutics, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$1.03 Billion
Q4 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$2.15 - $5.68 $1,489 - $3,936	693 Added 96.12%	1,414 $3,000
Q3 2023 Oct 30, 2023	BUY	$2.15 - $5.68 $1,489 - $3,936	693 Added 96.12%	1,414 $3,000
Q2 2023 May 21, 2024	SELL	$5.6 - $9.66 $140 - $241	-25 Reduced 3.35%	721 $4,000
Q2 2023 Jul 27, 2023	SELL	$5.6 - $9.66 $140 - $241	-25 Reduced 3.35%	721 $4,000
Q1 2023 May 21, 2024	BUY	$4.81 - $10.95 $1,240 - $2,825	258 Added 52.87%	746 $4,000
Q1 2023 Apr 27, 2023	BUY	$4.81 - $10.95 $1,240 - $2,825	258 Added 52.87%	746 $4,000
Q4 2022 May 21, 2024	BUY	$4.22 - $7.05 $2,059 - $3,440	488 New	488 $2,000
Q4 2022 Jan 31, 2023	BUY	$4.22 - $7.05 $168 - $282	40 Added 8.93%	488 $3,000
Q3 2022 Oct 21, 2022	BUY	$3.63 - $6.65 $1,626 - $2,979	448 New	448 $2,000

Others Institutions Holding OMGA

# of Institutions

Shares Held

43.3M

Call Options Held

25.8K

Put Options Held

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $6.22M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account